Rchr
J-GLOBAL ID：200901016371476131   Update date: Apr. 19, 2024

Kamada Haruhiko

カマダ ハルヒコ | Kamada Haruhiko
Affiliation and department：
National Institutes of Biomedical Innovation,Health and Nutrition

About National Institutes of Biomedical Innovation,Health and Nutrition


Job title： Project Leader
Other affiliations (4)：
  • National Institutes of Biomedical Innovation, Health and Nutrition
  • Kyoto University  Graduate School of Pharmaceutical Sciences 
  • Osaka University  Graduate School of Pharmaceutical Sciences 
  • Osaka University
Homepage URL  (1)： http://www.nibiohn.go.jp/bio-r/index.htm
Research field  (9)： Tumor diagnostics and therapeutics ,  Other ,  Clinical pharmacy ,  Hematology and oncology ,  Urology ,  Structural biochemistry ,  Pathobiochemistry ,  Pharmaceuticals - chemistry and drug development ,  Molecular biology
Research keywords  (16)： ファージ表面提示法 ,  炎症 ,  腫瘍壊死因子 ,  血管内皮細胞 ,  プロテオーム ,  疾患関連タンパク質 ,  炎症性メディエーター ,  炎症性たんぱく質 ,  バイオマーカー ,  乳がん ,  抗体 ,  プロテオミクス ,  血液学(血栓止血) ,  分子病態学 ,  Hematology(thrombosis and hemostasis) ,  molecular pathobiology
Research theme for competitive and other funds  (37)：
  • 2022 - 2025 Development of antibody design optimized for active targeting
  • 2022 - 2024 <混ぜる>抗体工学 ~二重特異性抗体の効率的な創出法の開発~
  • 2021 - 2024 機能性食品成分の腸管における標的分子の同定と腸内細菌叢への作用の解析
  • 2019 - 2022 Development of molecular targeted drug using high-resolution epitope mapping: a novel therapeutic strategy for intraocular fibrotic scarring
  • 2018 - 2021 Development of technology to search for novel antibody targets by proteomics specialized on the surface of circulating tumor cells
Show all
Papers (162)：
  • Yoji Tsugawa, Kentaro Furukawa, Tomoko Ise, Masahiro Takayama, Takeshi Ota, Takayuki Kuroda, Shinya Shano, Takashi Hashimoto, Haruyo Konishi, Takeshi Ishihara, et al. Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo. 2024
  • Masaki Inoue, Yuta Tsuji, Reira Ueno, Daisuke Miyamoto, Keisuke Tanaka, Yuka Moriyasu, Saya Shibata, Mei Okuda, Daisuke Ando, Yasuhiro Abe, et al. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells. Scientific reports. 2023. 13. 1. 13762-13762
  • Kentaro Nishiyama, Hiroki Akiba, Satoshi Nagata, Kouhei Tsumoto, Haruhiko Kamada, Hiroaki Ohno. A Proximity-Induced Fluorogenic Reaction Triggered by Antibody-Antigen Interactions with Adjacent Epitopes. Angewandte Chemie International Edition. 2023. 62. 30
  • Kensuke Suzuki, Masaki Tajima, Yosuke Tokumaru, Yuya Oshiro, Satoshi Nagata, Haruhiko Kamada, Miho Kihara, Kohei Nakano, Tasuku Honjo, Akio Ohta. Anti-PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases. Science immunology. 2023. 8. 79. eadd4947
  • Hiroki Akiba, Junso Fujita, Tomoko Ise, Kentaro Nishiyama, Tomoko Miyata, Takayuki Kato, Keiichi Namba, Hiroaki Ohno, Haruhiko Kamada, Satoshi Nagata, et al. Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection. 2022
ｍore...
MISC (186)：
  • Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, Satoru Nirasawa, Masamitsu Asaka, Mayumi Niiyama, Jianbo An, Daichi Utsumi, Satoshi Nagata, Haruhiko Kamada, et al. Therapeutic effects of angiotensin converting enzyme 2 (ACE2) enzyme activity on acute lung injury in COVID-19. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 95. 2-O
  • Utsumi Daichi, Masamitsu Asaka, Haruhiko Kamada, Satoshi Nagata, Yutaka Nakachi, Tomokazu Yamaguchi, Yoshihiro Kawaoka, Keiji Kuba, Yasuhiro Yasutomi. Establishment of SARS-CoV-2 respiratory tract infection model in CAG promoter-driven hACE2 transgenic mice. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2022. 95. 2-P
  • 田中佑弥, 谷奥有里花, 阿曽古都美, 中山泰亮, 鎌田春彦, 山口卓男, 小比賀聡. Synthesis and evaluation of lipid-modified antisense oligonucleotides. 日本薬学会年会要旨集(Web). 2021. 141st
  • Tomokazu Yamaguchi, Takafumi Minato, Midori Hoshizaki, Masamitsu Asaka, Satoru Nirasawa, Mayumi Niiyama, Masaki Imai, Saori Takahashi, Daichi Utsumi, Jianbo An, et al. Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19 mouse model. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2021. 94. 2-P2
  • 東阪和馬, 東阪和馬, 大須賀絵理, 笠原淳平, 豊田麻人, 尾花理徳, 鎌田春彦, 前田真貴子, 長野一也, 藤尾慈, et al. 心分泌蛋白質に着目した心不全に対する新規バイオマーカー探索. 日本薬学会年会要旨集(CD-ROM). 2018. 138th. 4. ROMBUNNO.27G-pm06-61
ｍore...
Books (1)：
  • 図説分子病態学
    中外医学社 2008
Education (4)：
  • - 2000 Osaka University
  • - 2000 Osaka University Graduate School, Division of Pharmaceutical Sciences
  • - 1995 Osaka University School of Pharmaceutical Sciences
  • - 1995 Osaka University Faculty of Pharmaceutical Science
Professional career (1)：
  • PhD (Osaka University)
Work history (9)：
  • 2016 - 現在 National Institutes of Biomedical Innovation, Health and Nutrition CDDR Project Leader
  • 2010 - 2016 National Institutes of Biomedical Innovation, Health and Nutrition
  • 2005 - 2010 National Institutes of Biomedical Innovation, Health and Nutrition
  • 2007 - 2008 Swiss Federal Institute of Technology Guest Researcher
  • 2004 - 2005 国立医薬品食品衛生研究所 大阪支所 主任研究官
Show all
Committee career (1)：
  • 2003 - 日本血栓止血学会 小委員会 動物モデル
Awards (4)：
  • 2019/02 - Osaka Bio Headquater Grand prize Functional antibody creation technology for development of antibody drug
  • 2011/07 - International Society of Thrombosis and Hemostasis Asian-Pacific Scholarship Creation of TNFR1-selective mutant TNF with antagonistic activity.
  • 2006 - 武田科学振興財団 薬学系研究奨励
  • 1998 - 日本薬剤学会優秀論文賞
Association Membership(s) (7)：
THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  日本DDS学会 ,  日本プロテオーム機構 ,  日本薬学会 ,  日本生化学会 ,  日本血栓止血学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM